Drug intelligence / Profile preview

collagen + bone marrow mononuclear cells

Development stage
Phase 2
Lead developer
Institute of Genetics and Developmental Biology, Chinese Academy of Sciences
Modality
Cell Therapies
Administration
Surgical Implantation, Intralesional, Intraosseous
01

Overview

Collagen + bone marrow mononuclear cells (BMMNCs) is a regenerative medicine combination therapy consisting of a three-dimensional collagen scaffold seeded with autologous bone marrow mononuclear cells. The collagen scaffold, often bovine-derived and specifically engineered (such as the NeuroRegen scaffold), serves as a physical bridge to facilitate axonal regeneration across tissue gaps, particularly in the central nervous system. The BMMNCs, a heterogeneous population including hematopoietic stem cells, mesenchymal stem cells, and progenitor cells, act primarily through paracrine mechanisms. They secrete neurotrophic factors and immunomodulatory cytokines that create a permissive environment for neural repair, reduce inflammation, and support the survival of endogenous cells. This approach is primarily investigated for the treatment of complete spinal cord injury (SCI) to restore motor and sensory function.

Other names
collagen + BMMNCscollagen scaffold + bone marrow mononuclear cellsBMMNC-loaded collagen scaffoldNeuroRegen scaffold + BMMNCs

Beyond the preview

Go deeper on collagen + bone marrow mononuclear cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on collagen + bone marrow mononuclear cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call